The Market Reports: Peripheral Thrombectomy Devices Global Market Analysis and Forecast Model

Peripheral Venous Thrombectomy devices are used for the removal of a clot from a blood vessel to restore proper blood circulation. This device is used as a routine procedure while performing Percutaneous Coronary Intervention and to treat potentially life threatening complications such as deep vein thrombosis (DVT) and pulmonary embolism (PE).

Thrombectomy System (Catheters), Manual Aspiration Thrombectomy Devices, Rotational Thrombectomy Devices and Embolectomy Ballooon Catheters are tracked under this category.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Report Source:


This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Peripheral thrombectomy devices marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Purchase this report at:

Key companies covered in this report are Boston Scientific Corp, EKOS Corp, Penumbra Inc, Teleflex Inc, Argon Medical Devices Inc, Straub Medical AG, Edwards Lifesciences Corp, Terumo Medical Corp, Spectranetics Corp, Merit Medical Systems Inc and more.

Reasons To Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Peripheral thrombectomy devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Peripheral thrombectomy devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Peripheral thrombectomy devices market from 2015-2028.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Got a question; ask us at:   

Posted by on Tuesday June 18 2019, 3:07 AM EDT. All trademarks acknowledged. Filed under Featured Press Release, Life Sciences. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Latest News

Log in